date:Jun 19, 2012
aged between 40 and 70 to participate in their three-month, double-blind, randomized, placebo-controlled, parallel-group trial.
Participants were randomly assigned to receive either 4 grams per day of cis-9, trans-11 CLA-enriched oil or placebo oil, consisting of palm oil and soybean oil.
Using proteomic techniques the researchers deduced that CLA supplementation producedsignificant alterations in levels of 46 spots of which 40 were identified.
Changes to proteins such as CDC42hs, alpha-acti